Background
==========

With the sequencing of the human genome completed and with mRNA/cDNA identification rapidly progressing, many potential novel genes have been discovered and attention has turned to the function and structure of the predicted proteins \[[@B1]-[@B4]\]. In order to study these novel gene products, sufficient amounts of protein generally obtained through recombinant protein expression are required. The (high-throughput) expression and characterisation of unknown and poorly characterised human proteins is a main objective of recombinant proteomic studies today.

*Escherichia coli*is the most commonly used prokaryotic expression system for the high-level production of recombinant proteins *in vivo*\[[@B5]\] and has already been used successfully in high-throughput protein expression and purification studies \[[@B4],[@B6]\]. The use of *E. coli*has many advantages, including the ease of growth and manipulation of the organism and the availability of many different vectors and host strains that have been developed over the years. However, the use of *E. coli*also has limitations, such as the aggregation of protein in insoluble inclusion bodies, problems with the expression of gene products toxic to the physiology of the host cell or proteolytic degradation of proteins in the cytoplasm \[[@B7]\]. In light of these difficulties, cell-free expression systems are becoming increasingly popular \[[@B8]-[@B14]\]. The *in vitro*systems have several advantages, including rapid protein synthesis \[[@B15]\], the possibility to express toxic gene products \[[@B16]\] and constructs that otherwise would be proteolytically degraded. Furthermore, it is possible to express proteins with up to 10 putative transmembrane domains as reported recently \[[@B17]\]. The compatibility with PCR-generated templates as well as plasmids allows the *in vitro*expression reaction with *E. coli*extract to be optimised using silent mutations within PCR products \[[@B18]\]. These sequence optimisations reduce unfavourable secondary structures in mRNA and thus improve the success rate of translation and protein expression. In contrast, for cell-free protein expression with wheat germ lysate sequence optimisation is not necessary because of the eukaryotic nature of this source.

For protein expression analyses, a comprehensive cDNA collection is available at the German Ressource Center (RZPD). The full-length open reading frames (ORFs) are cloned into an entry vector by utilizing the Gateway^®^cloning technology (Invitrogen). Untranslated regions are excluded and only the open reading frame is cloned into the selected vector, either with or without a stop codon. For protein expression, the open reading frame can be moved into any desired expression vector by homologous recombination. Thus, a protein can be expressed with or without a tag and the tag itself can easily be selected and altered by choosing the appropriate destination vector.

The aim of this study was to evaluate alternatives to protein expression in *E.coli in vivo*especially for those ORFs yielding no protein in this system. Therefore we investigated protein expression in two different *in vitro*systems: *E. coli*and wheat germ extract. The performance of these systems was analysed and optimised in respect to expression rate, protein yield and solubility. Altogether, we tested the expression of 960 human full-length proteins *in vivo*and *in vitro*using standardised conditions.

Results
=======

Comparison of *in vivo*and *in vitro*Escherichia coli expressions
-----------------------------------------------------------------

We used 960 randomly selected fully sequence-verified human open reading frames with a broad range of expected molecular weights (from less than 8 kDa up to 134 kDa, average of 35 kDa), different predicted subcellular localisations and biochemical functions including membrane proteins. The ORFs were cloned into an expression vector (pDEST17-D18), for production of proteins with an N-terminal 6xHis-tag. Identical constructs were used for protein expression *in vitro*and also for transformation of bacteria and expression *in vivo*. Protein expression was analysed by western blotting using an anti-His antibody.

In *E. coli in vivo*629 out of 960 proteins, and *in vitro*456 out of 960 proteins were successfully expressed. Protein expression in bacteria was unsuccessful either because clones were generated, which did not show protein expression (233 samples) or the transformation failed completely (98 samples). Considering the overlap of both expression systems, 206 full open reading frames yielded no protein product *in vivo*[and]{.ul}*in vitro*. In contrast, 331 targets were expressed *in vivo*[and]{.ul}*in vitro*with an average molecular weight of 33 kDa. Among these, 57 clones showed an expression rate of 4, 86 clones of 3 and 7 clones of 2. Furthermore, 424 targets expressed in either system with an average moleclar weight of 32 kDa.

Optimisation of *E. coli*expression *in vitro*
----------------------------------------------

We next examined the effect of sequence optimisation on protein expression rate and protein yield by selecting randomly 87 out of the 960 ORFs (Figure [1](#F1){ref-type="fig"}, Table [1](#T1){ref-type="table"}) where protein expression had been unsuccessful *in vivo*or where transformation had failed in BL21(DE3)pLysS. Three kinds of linear PCR templates were generated (Figure [2](#F2){ref-type="fig"}): (i) a C-terminal wild type with C-terminal 6xHis-tag (ii) a C-terminal mutant with C-terminal 6xHis-tag and inserted silent mutation at the N-terminus (iii) a N-terminal wild type with N-terminal 6xHis-tag and no attachment sites (att-sites); For the C- and N-terminal wild type template the ORF is identical to the original ORF in the plasmid DNA.

###### 

Subset of 87 clones tested in *E. coli in vitro*and in wheat germ expression. ORF Nr.: Clone identifier; RZPD Clone ID: Available clones at RZPD GmbH; Hit Acc. Nr.: Best BLAST hit of DNA sequence. Molecular weight was calculated by translation of the DNA sequence. Expression/solubility were assigned values from 0 (no expression/no protein detectable in the supernatant) to 4 (very strong band/protein band in the supernatant is stronger than in the pellet). The column \'yielded by\' is indicated as follows: WG C: wheat germ C-terminal, WG: wheat germ, C- and N-terminal, WG N: wheat germ, N-terminal, RTS CW: *E. coli in vitro*C-terminal wildtype, RTS CM: *E. coli in vitro*C-terminal mutant, RTS NW: *E. coli in vitro*N-terminal wildtype, RTS Pl: *E. coli in vitro*original plasmid.

  **ORF Nr**   **RZPDCloneID**   **Hit Acc No**   **Gene symbol**   **Mw in kDa**   **Best expr. rate**   **Yielded by**     **Best solubility**
  ------------ ----------------- ---------------- ----------------- --------------- --------------------- ------------------ ---------------------
  264          RZPDo834B052      NM_001677        ATP1B1            36              4                     RTS NW             3
  400          RZPDo834D022      NM_002573        PAFAH1B3          27              4                     WG, RTS CM NW      4
  433                            NM_000318        PXMP3             32              4                     WG, RTS CW CM NW   4
  464          RZPDo834F012      NM_006793        PRDX3             29              4                     WG C, RTS CM       4
  505                            NM_003187        TAF9              30              4                     WG                 3
  531                            NM_012222        MUTYH             23              4                     WG                 3
  562          RZPDo834B043      NM_000075        CDK4              35              4                     RTS CM NW Pl       3
  571          RZPDo834B083      NM_003182        TAC1              13              4                     WG C, RTS CW CM    4
  616          RZPDo834D033      NM_000550        TYRP1             61              3                     RTS Pl             2
  636                            NM_000612        IGF2              22              4                     WG C, RTS CW CM    4
  637          RZPDo834E013      NM_015646        RAP1B             22              4                     WG, RTS CW CM NW   4
  639                            NM_002512        NME2              14              4                     WG N, RTS NW       3
  690          RZPDo834F123      NM_006923        SDF2              23              4                     WG C, RTS CW CM    4
  694          RZPDo834G023      NM_020470        YIF1              32              4                     WG N               3
  728          RZPDo834E0511     NM_000434        NEU1              46              4                     RTS NW             2
  741          RZPDo834H073      NM_002799        PSMB7             30              4                     WG C               4
  772          RZPDo834C0311     NM_002804        PSMC3             46              4                     WG N, RTS CM       4
  777          RZPDo834C0411     NM_003908        EIF2S2            39              4                     WG                 4
  831                            NM_004394        DAP               12              3                     WG                 4
  832                            NM_002966        S100A10           12              4                     WG, RTS CM NW      4
  833          RZPDo834A124      NM_017503        SURF2             30              4                     WG C               4
  840          RZPDo834B024      NM_005499        UBA2              72              3                     WG C               4
  842                            NM_005942        MOCS1             24              4                     WG N, RTS CM       3
  855                            NM_002134        HMOX2             36              4                     RTS NW             4
  861          RZPDo834C034      NM_006370        VTI1B             27              4                     WG N, RTS NW Pl    3
  868          RZPDo834C084      NM_005892        FMNL1             53              4                     WG, RTS CM NW      3
  873          RZPDo834C104      NM_007363        NONO              55              4                     WG C               3
  881                            NM_002622        PFDN1             15              4                     WG C               4
  898          RZPDo834D114      NM_006117        PECI              21              4                     WG N, RTS CW       4
  901          RZPDo834E024      NM_031263        HNRPK             51              4                     RTS CW NW          4
  904                            NM_004401        DFFA              13              4                     WG N               4
  906                            NM_006693        CPSF4             31              4                     WG C, RTS CM       4
  915          RZPDo834F024      M55654           TBP               38              4                     WG N, RTS NW Pl    3
  918                            NM_004184        WARS              54              3                     WG N               4
  921          RZPDo834F064      NM_004309        ARHGDIA           23              4                     RTS CM NW          3
  924          RZPDo834F094      NM_002861        PCYT2             44              4                     WG C               4
  930          RZPDo834G014      NM_001551        IGBP1             40              4                     WG, RTS Pl         4
  932          RZPDo834G034      NM_002070        GNAI2             41              4                     WG C, RTS NW Pl    4
  935                            NM_001014835     PAK4              64              2                     WG C               3
  936          RZPDo834G064      NM_002074        GNB1              38              3                     RTS NW             3
  939          RZPDo834G074      NM_006321        ARIH2             58              3                     WG C, RTS Pl       4
  940          RZPDo834G084      NM_013296        GPSM2             55              2                     WG C               4
  943          RZPDo834G114      NM_001863        COX6B1            11              4                     WG, RTS CW CM Pl   4
  944                            NM_004537        NAP1L1            46              4                     WG                 4
  945          RZPDo834H014      NM_152925        RBM12             59              4                     WG C               4
  947          RZPDo834H034      NM_001017957     OS-9              70              4                     WG C               4
  1033                           NM_007317        KIF22             74              0                                        0
  1068                           NM_206900        RTN2              52              4                     WG C               4
  1082                           NM_018074        FLJ10374          37              4                     WG; RTS CW CM      4
  1091                           NM_001512        GSTA4             26              4                     WG                 4
  1093         RZPDo834A015      NM_001647        APOD              22              4                     WG C, RTS CM       4
  1101                           NM_001643        APOA2             12              4                     WG N               3
  1115                           NM_007261        CMRF-35H          25              4                     WG, RTS CM NW      4
  1189         RZPDo834H106      NM_001425        EMP3              19              4                     WG                 4
  1294         RZPDo834A035      NM_014876        KIAA0063          24              4                     WG                 4
  1330                           NM_002816        PSMD12            53              4                     WG C               4
  1453         RZPDo834B115      NM_198216        SNRPB             25              4                     WG C, RTS CM       3
  1454         RZPDo834H0711     NM_006841        SLC38A3           56              4                     WG, RTS NW         3
  1461         RZPDo834C025      NM_004047        ATP6V0B           22              3                     WG C               1
  1462         RZPDo834C035      NM_003145        SSR2              21              4                     WG C, RTS CM       3
  1480                           NM_000984        RPL23A            18              3                     WG                 4
  1485         RZPDo834D025      NM_014860        SUPT7L            47              4                     WG                 4
  1487         RZPDo834D035      NM_198120        EBAG9             25              4                     WG C               3
  1533         RZPDo834F075      NM_013300        HSU79274          31              4                     WG C               3
  1554         RZPDo834G095      NM_001778        CD48              28              4                     RTS NW             3
  1555         RZPDo834G105      NM_019111        HLA-DRA           29              4                     RTS CM             3
  1575         RZPDo834H085      NM_004233        CD83              23              4                     WG, RTS CM         4
  1576         RZPDo834H095      NM_007024        PL6               39              2                     WG N               1
  1642                           NM_003490        SYN3              64              2                     WG                 4
  1670                           NM_006841        SLC38A3           56              4                     WG N, RTS NW       3
  1734         RZPDo834F0511     NM_001436        FBL               34              4                     WG C               4
  1736         RZPDo834G0511     NM_004343        CALR              49              4                     WG C               4
  2066                           NM_015723        PNPLA8            89              0                                        0
  2225         RZPDo834H0221     NM_018127        ELAC2             93              0                                        0
  2229         RZPDo834A046      NM_00513         REC8L1            63              3                     WG C, RTS CM       4
  2504                           NM_199053        FLJ12716          65              4                     RTS CW CM NW       3
  2724                           NM_173157        NR4A1             65              4                     WG N               2
  2871                           NM_018099        MLSTD1            60              4                     RTS CW CM NW       3
  2938         RZPDo834H0421     NM_015072        TTLL5             92              0                                        0
  2949         RZPDo834E1121     NM_020748        KIAA1287          135             0                                        0
  2959                           NM_021932        RIC8              17              4                     WG, RTS Pl         4
  2962         RZPDo834H0621     NM_014149        HSPC049           78              2                     RTS CM NW          0
  2964         RZPDo834F1121     NM_003263        TLR1              91              4                     RTS CM NW          4
  2968         RZPDo834G0821     NM_001040428     SPATA7            65              4                     RTS CW CM NW       3
  2973                           NM_032292        FLJ20203          91              4                     RTS CW CM NW       3
  2978         RZPDo834H0721     NM_014585        SLC40A1           63              0                                        0
  2979         RZPDo834E0821     NM_013277        RACGAP1           71              4                     RTS CM             0

![Scheme of the experimental strategy. Successful protein expression is indicated by +, unsuccessful protein expression by -.](1472-6750-7-64-1){#F1}

![Optimised linear templates for *E. coli in vitro*expression. Three kinds of linear PCR-products were generated to investigate the effect on protein expression rate and yield. (i) C-terminal wild type with C-terminal 6xHis-tag (ii) C-terminal mutant with C-terminal 6xHis-tag and inserted silent mutation at the N-terminus (iii) N-terminal wild type with N-terminal 6xHis-tag and no attachment sites (att-sites); For the C- and N-terminal wild type template the ORF is identical to the original ORF in the plasmid DNA.](1472-6750-7-64-2){#F2}

Influence of sequence optimisation on protein expression rate
-------------------------------------------------------------

Of these 87 samples, 37 samples (43%) were successfully expressed *in vitro*using the original plasmid DNA. After sequence optimisation, we increased the success rate of protein expression up to 74 samples (85%) in the cell-free *E. coli*system (Figure [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}).

![Comparison of *in vitro*expression of 87 targets in *E. coli*and wheat germ.](1472-6750-7-64-3){#F3}

![*E.coli*expression *in vitro*. Presented are western blots of 8 targets expressed with C-terminal wild type, C-terminal mutant, N-terminal wild type and original plasmid DNA templates (from left to right). Successful protein expression was defined for values 2 -- 4 and unsuccessful protein expression for values of 0 and 1. Bands of the expected size are marked with a +.](1472-6750-7-64-4){#F4}

When analysing the results of those samples which had previously not shown expression *in vitro*(50 samples), we found that following sequence optimisation 37 (74%) proteins were expressed.

Influence of sequence optimisation on protein yield
---------------------------------------------------

To assess the protein expression yield of PCR products after sequence optimisation, we evaluated 37 samples that had previously expressed protein *in vitro*from original plasmid DNA. Protein yield was determined by analysis of protein bands on western blots. Bands were given marks from 0 (no expression) to 4 (very strong). Here, we discovered that 65% of expressions (24 samples) showed an improvement in the protein yield compared to expressions using original plasmid DNA and another 19% showed similar protein yields. A smaller amount of protein was expressed in only 6 cases (16%) using the optimised PCR products. Among these were 3 samples which did not express protein at all. In summary, after analysis of 87 expressions *in vitro*with optimised PCR-products, 16 samples (18%) revealed no protein product *in vivo*or *in vitro*in the *E. coli*systems (Table [2](#T2){ref-type="table"}).

###### 

Proteins not expressing in *E. coli in vitro*or in wheat germ or in both systems. Molecular weight was calculated by translation of the DNA sequence. Localization information was taken from the Uniprot database. Domain information was retrieved from the Pfam database: cc: coiled coil, tms: transmembrane segment, sp signal peptide. Empty fields correspond to no assignment in the database.

  Hit Acc. No.   Gene symbol   Mw in kDa   Localization    Domains      Expression in *E. coli in vitro*   Expression in wheat germ
  -------------- ------------- ----------- --------------- ------------ ---------------------------------- --------------------------
  NM_007317      KIF22         74          nuclear         1cc,,        no                                 no
  NM_015723      PNPLA8        89          membrane                     no                                 no
  NM_020748      KIAA1287      135         n/a                          no                                 no
  NM_018127      ELAC2         93          nuclear                      no                                 no
  NM_015072      TTLL5         92          n/a             3cc,,        no                                 no
  NM_014585      SLC40A1       63          membrane        ,,10tms      no                                 no
  NM_020470      YIF1A         32          membrane        ,,5tms       no                                 yes
  NM_004394      DAP           12          secreted                     no                                 yes
  NM_001014835   PAK4          64          n/a                          no                                 yes
  NM_013296      GPSM2         55          n/a                          no                                 yes
  NM_006812      OS-9          70          n/a             1cc1sp1tms   no                                 yes
  NM_014860      SUPT7L        47          n/a             1cc,,        no                                 yes
  NM_003908      EIF2S2        39          nuclear                      no                                 yes
  NM_006321      ARIH2         58          nucleus         2cc,,        no                                 yes
  NM_002816      PSMD12        53          cytosol         1cc,,        no                                 yes
  NM_000984      RPL23A        18          cytosol                      no                                 yes
  NM_002134      HMOX2         36          microsomal      1cc,1tms     yes                                no
  NM_018099      MLSTD1        60          intracellular   ,,2tms       yes                                no
  NM_013277      RACGAP1       71          intracellular   1cc,,        yes                                no
  NM_003263      TLR1          91          membrane        1sp,1tms     yes                                no
  NM_032292      FLJ20203      91          n/a             1cc,,        yes                                no
  NM_014149      HSPC049       78          n/a             1cc,,        yes                                no

Wheat germ expression *in vitro*
--------------------------------

The aim of this experiment was to elucidate whether the wheat germ system would show an increase in the success rate and protein yield of the 87 selected open reading frames compared to the optimised *in vitro*expressions in *E. coli*. Two wild type PCR constructs were made for each open reading frame, one for production of a protein with a C-terminal 6xHis-tag and another for a protein with a N-terminal 6xHis-tag (Figure [5](#F5){ref-type="fig"}). A total of 75 proteins could be expressed in wheat germ lysate with either a C- or a N-terminal 6xHis-tag (86%, Figure [3](#F3){ref-type="fig"}). Out of the 16 open reading frames which were not expressed in the *E. coli*systems, 10 were now successfully expressed using wheat germ lysate (Table [2](#T2){ref-type="table"}). However, 6 open reading frames did not express in the wheat germ system, but were previously successfully expressed *in vitro*in *E. coli*(Table [2](#T2){ref-type="table"}). On average, based on western blotting analyses, the protein yield was higher in the wheat germ compared to expressions in the *E. coli in vitro*system, for identical human ORFs.

![Wheat germ expression *in vitro*. Presented are western blots of 8 targets expressed with C-terminal (left) and N-terminal (right) 6xHis-tag. ORF Nr.: clone identifier. GUS: glucuronidase is the positive control. Successful protein expression was defined for values 2 -- 4 and unsuccessful protein expression for values of 0 and 1. Bands of theexpected size are marked with a +.](1472-6750-7-64-5){#F5}

Influence of tag position on protein expression *in vitro*
----------------------------------------------------------

To assess the influence of either N- or C-terminal tag positions on expression rate, the 87 open reading frames were evaluated in both *in vitro*expression systems, *E. coli*and wheat germ (Figure [6](#F6){ref-type="fig"}). In the *E. coli in vitro*system, protein expressions using optimised PCR products were evaluated. Here, 52 (60%) N-terminal tagged wild type PCR products expressed protein compared to only 30 (34%) with C-terminal wild type PCR products (Figure [4](#F4){ref-type="fig"}). With the C-terminal mutant product 51 (59%) proteins were expressed. In the wheat germ system, 65 were expressed using the N-terminal wild type construct (75%) and 67 with the C-terminal tag (78%) (Figure [5](#F5){ref-type="fig"}).

![Influence of tag on *in vitro*expression. We compared 87 targets expressed in *E.coli in vitro*and in wheat germ. C-term. wt: C-terminal wild type; C-term. mutant: C-terminal mutant; N-term. wt: N-terminal wild type.](1472-6750-7-64-6){#F6}

In summary, 81 out of 87 open reading frames were expressed in both *in vitro*systems, corresponding to a success rate of 93%. Only 6 ORFs yielded no protein in any of the systems tested (Table [2](#T2){ref-type="table"}).

Comparison of solubility of proteins expressed in *E. coli in vivo*, *in vitro*and in wheat germ system
-------------------------------------------------------------------------------------------------------

For solubility studies, the lysis supernatant of those targets revealing expression was analysed by western blot. 483 proteins, expressed in *E. coli in vivo*, were tested and 193 proteins were soluble (40%). For *E. coli*expressions *in vitro*(with original plasmid DNA), 388 were analysed and 185 proteins were soluble (48%). In the wheat germ system with a C-terminal 6xHis-tag 66 of the 68 (97%) expressing PCR products showed soluble protein and 95% with an N-terminal 6xHis-tag.

Discussion and conclusion
=========================

With this approach we evaluated the performance of three different protein expression systems *in vivo*and *in vitro*with a set of 960 full-length open reading frames. For our investigations of protein synthesis we chose *Escherichia coli*bacteria as it is one of the most common and easy to use systems. For cell-free *in vitro*expression, we compared the *E. coli*with the wheat germ protocol.

First, we analysed the protein expression rate in the two *E. coli*systems (*in vitro*and *in vivo*) and found that expression is higher in the *in vivo*system (66% compared to 48%). Regarding the success rate of both protocols, only 22% of plasmids yielded no protein.

We then focused on a subset of 87 targets which had yielded no protein in *E. coli in vivo*. These targets expressed with the cell-free wheat germ and *E. coli*protocol yielded very different protein expression rates. In wheat germ 86% of the targets were expressed and in cell-free *E. coli*only 43%. One of the reasons for unsuccessful *in vitro*protein expression in *E. coli*may be the presence of secondary structures in mRNA, which may inhibit translation \[[@B19]\]. To solve this problem, we made use of the ProteoExpert software, which predicts possible sequence-related problems and proposes optimised sequences with potentially reduced unfavourable secondary structures \[[@B18],[@B20]\]. Out of the 87 proteins that were not expressed in *E. coli in vivo*, 37 were expressed *in vitro*using the wild type sequence. Another set of 37 human proteins could be rescued by sequence optimisation and using linear templates for *in vitro*expression. Therefore, the overall success rate of *in vivo*negative clones was 85%. This result clearly demonstrates that sequence optimisation is necessary to improve protein synthesis in the *E. coli in vitro*system.

Furthermore, we analysed the influence of tag position on protein expression rate. We found no difference between C- or N-terminal tag in the wheat germ system. However, considering the cell-free *E. coli*system, 60% successful expression was obtained with the N-terminal wild type PCR product in contrast to only 34% with the C-terminal one. In this context it is important to realize that this 60% expression with the N-terminal tag matches with the 59% obtained with the C-terminal mutant. Obviously, modifying the sequence by adding a sequence optimised peptide tag also avoids expression problems associated with the inition of translation.

After analysis of the 87 optimised expressions *in vitro*, 6 samples remained that were not expressed *in vivo*or *in vitro*(Table [2](#T2){ref-type="table"}). This corresponds to a protein expression success rate of 93%. Regarding those proteins, which could not be expressed in either system, it is striking that the molecular mass of all of these targets is higher than 63 kDa with an average molecular weight of 91 kDa. Two membrane associated proteins belong to the unsuccessful targets: PNPLA8 (89 kDa) and SLC40A1 (63 kDa), the latter with more than 10 transmembrane domains. Furthermore, a DNA binding protein KIF22 (74 kDa) of the Kinesin family, involved in spindle formation, ELAC2 (93 kDa) an endonuclease, TTLL5 (92 kDa), a tubulin tyrosin ligase-like protein and KIAA1287 (135 kDa), a hypothetical protein with one transmembrane domain, are among the non-expressing targets. At this point it is unclear whether these human proteins are functionally expressed in any of the systems. Therefore, we can not speculate about the interference between the protein function and the different expression systems.

However, 6 proteins with an average molecular weight of 72 kDa were expressed in *E. coli in vitro*but not in wheat germ. Among these proteins is HMOX2 which belongs to the heme oxygenase family, an iron-containing protein with one transmembrane domain. As reported recently, iron-containing proteins require supplemented iron sources which were not added in this case \[[@B21]\]. Further proteins are two with transmembrane domains (MLSTD1 with two transmembrane domains and TLR1 with one). The three proteins RACGAP1, FLJ20203 and HSPC049 each contain one coiled coil domain and have molecular weights higher than 70 kDa. Obviously, the expression of proteins with molecular weights higher than 70 kDa are critical for the wheat germ system \[[@B22]\].

Ten proteins with an average molecular weight of 45 kDa also remain which were expressed in wheat germ but not in *E. coli in vitro*. An explanation for this can not be found in the structural domains, because a coiled coil and one transmembrane domain were not a hindrance for expression of the proteins mentioned before. Also the molecular weight is not the problem. Regarding the function of these proteins, SUPT7L (transcription regulation factor), EIF2S2 (translation initiation factor) and RPL23A (rRNA binding protein) are proteins which interfere with DNA or RNA. It seems that those proteins are likely to have negative effects on their recombinant expression, when functional active in *E.coli*cells. Also proteins influencing the cell cycle like DAP (involved in cell death), KIAA1142 (has a kinase motif), PAK4 (kinase, involved in the JNK pathway), GPSM2 (a signalling modulator) and OS-9 (influences cell growth viability) seem to hamper recombinant protein expression.

Based on western blotting analyses, the protein yield in wheat germ was higher compared to expressions in the *E. coli in vitro*. This may be due to the fact that the *in vitro E. coli*expression system is a batch method for protein expression, whereas the wheat germ system is based on a two-compartment system. The two chambers are separated by a semi-permeable membrane which concentrates the expressed protein in the 50 μl reaction chamber, but lets compounds required for protein synthesis such as substrates and energy components pass through into the larger feeding chamber. At the same time, potentially inhibitory by-products are diluted via diffusion across the membrane. The wheat germ system showed the highest rate of success compared to expression in *E. coli in vitro*or *in vivo*. Thus, for *in vitro*protein expression, specifically for toxic proteins which can not be expressed in bacteria, the wheat germ system is the method of choice.

Comparing protein solubility in *E. coli*bacteria and the cell-free *E. coli*and wheat germ systems, we found that the wheat germ system produces the highest solubility rate (97%). This was also reported previously \[[@B22]\]. It should be mentioned that our experimental procedure does not exclude the formation of protein aggregates. Moreover, the data show that the proteins expressed *in vitro*are more likely to be soluble than those expressed *in vivo*. However, even though the *E. coli in vivo*expressions showed, in a first approach, a higher success rate than *in vitro*, the *in vitro*system does have advantages. Protein expression is very fast and can be accomplished within a few hours. The expression of toxic gene products allows proteins to be expressed, which are impossible to express in bacteria. Also the use of PCR products is possible, and no clones are necessary for protein expression. However, linear DNA needs to be protected during the in vitro reactions to suppress nuclease activity. In addition, proteins are also more likely to be soluble when expressed in any of the *in vitro*systems used compared to expression in bacteria.

In summary, we have demonstrated that cell-free protein expression leads to the desired full-length protein with an overall success rate of up to 93%. In our study, wheat germ expression using a two compartment system is the method of choice as it shows high solubility and high protein yield.

Methods
=======

Expression-vector construction
------------------------------

The genes used in this study are available from the RZPD full-ORF clone collection. Entry clones containing the genes of interest were generated by utilising the Gateway^®^Cloning technology (Invitrogen). All entry clones were fully sequenced in order to verify the insert within pDONR201. From the entry clone, the ORF was sub-cloned to a Gateway^®^destination vector (pDEST17-D18, a modification of pDEST17, Invitrogen) creating an expression clone (LR reaction), which was then transformed into DH10B bacteria. Plasmid DNA of individual clones was used for transformation of BL21 (DE3) pLysS bacteria and for protein expression *in vivo*as well as for protein expression in the cell-free *E. coli*system. The pDEST17-D18 <http://www.rzpd.de> destination vector was used to express selected recombinant proteins controlled by the T7 promoter with an N-terminal 6xHis-tag. Identical constructs were used for protein expression in *E. coli*as well as for expressions in the cell-free *E. coli*system. All DNA preparations were carried out by a Qiagen Biorobot 9600 using Qiawell 96 Ultra Plasmid Kits (Qiagen).

*In vivo*protein expression using *E. coli*bacteria
---------------------------------------------------

Competent BL21 (DE3) pLysS (Novagen) bacteria were transformed with plasmid DNA (pDEST17-D18 containing the gene of interest). The generated expression clones were cultured overnight, diluted 1:50 to a final volume of 3 ml, and incubated in 24-well plates at 30°C or 3.5 h (until the OD~600~was 0,4--0,6). Expression was induced with 1 mM IPTG and bacteria cultured for a further 3,5 h at 30°C. Cells were harvested by centrifugation. A 5 μl aliquot of cell-pellet was removed and added to 45 μl of SDS sample buffer. 10 μl of the sample were then loaded onto a gel for western blotting analysis. An aliquot of the original sample was also saved for analysis of protein solubility.

*In vitro*protein expression (*E. coli*) using vector DNA
---------------------------------------------------------

*In vitro*protein expression was carried out using pDEST17-D18 plasmid DNA containing the ORF of interest. A cell-free batch expression system (RTS 100 *E. coli*HY kit, Roche Diagnostics) was utilised and 50 μl reactions were prepared according to the manufacturer\'s instructions. In brief, the samples were incubated at 30°C for 4 hours in a thermal cycler. Green fluorescent protein was expressed as control protein. Following incubation, a 5 μl aliquot was removed and added to 45 μl of SDS sample buffer. 10 μl of sample were then loaded onto a gel for Western blotting analysis. An aliquot of the original sample was also saved for analysis of protein solubility.

*In vitro*protein expression (*E. coli*) using optimised linear PCR products
----------------------------------------------------------------------------

Three PCR products were created for each ORF, a C-terminal wild type, a C-terminal mutant and a N-terminal wild type product (Figure [2](#F2){ref-type="fig"}). Sequence-verified templates were applied for the amplification of PCR products with the Linear Template Generation Set (LTGS, Roche Diagnostics). For the C-terminal mutant template, silent mutations as proposed by ProteoExpert <http://www.proteoexpert.com> were introduced at the N-terminus of the sequence. PCR was performed using partially matching primers along the first 15 to 20 nucleotides of each ORF. One gene-specific sense primer containing silent mutations, one gene-specific anti-sense and one wild type primer were used to produce the first PCR product. Different primers were applied depending on whether a C- or a N-terminal 6xHis-tag was desired. The PCR products were checked on agarose gels, and the second amplification step was carried out according to the supplier\'s instructions. As positive control protein, green fluorescent protein was expressed. Prior to *in vitro*expression, all products were verified for correct size and purity. *In vitro*expression was carried out according to instructions and SDS samples prepared.

*In vitro*protein expression (wheat germ) using linear PCR products
-------------------------------------------------------------------

Specific PCR products were generated to achieve translation in wheat germ lysate. The first wild type PCR product generated for optimisation in the *E. coli in vitro*system was utilised to produce a second PCR product for the wheat germ system. Linear templates with a T7 promoter and a Kozak sequence were generated for protein expression in wheat germ lysate. In contrast to PCR products created for the *E. coli in vitro*system, these products did not contain silent mutations. The first PCR products were made using gene-specific primer pairs and the second amplification step was carried out by the RTS Wheat Germ LTGS kit (Roche Diagnostics) according to instructions. The PCR products were again checked for correct size and purity. Proteins were expressed using the RTS 100 Wheat Germ CECF kit (Roche Diagnostics, positive control: glucuronidase) and contained either a C- or an N-terminal 6xHis-tag. Samples (50 μl) were incubated at 24°C, 900 rpm for 24 h (ProteoMaster Instrument, Roche Diagnostics), SDS samples prepared for western blotting and an aliquot saved for analysis of protein solubility.

Analysis of protein solubility
------------------------------

An aliquot of the induced bacterial culture was mixed with a lysis reagent (Pop Culture Reagent, Novagen) and 0.1% Tween 20 and incubated for 10 min at room temperature. The sample was centrifuged at 10000 g for 20 min, the supernatant and the pellet were separated and SDS samples prepared for western blotting analysis. For the *in vitro*systems, samples were centrifuged directly and the pellet and supernatant separated. Results were expressed as values ranging from 0 (no protein detectable in the supernatant) to 4 (the protein band in the supernatant is stronger than in the pellet). Values of 0 to 1 were defined as insoluble and values of 2 to 4 as soluble protein. Values correspond to: 4 \> 70%; 3 \> 40%; 2 \> 10%; 1 \< 10% solubility; 0 = unsoluble.

Western blotting
----------------

Western blotting was performed with the Criterion System (BioRad) and 10--20% gradient pre-cast gels. Samples (10 μl) were heated at 95°C for 5 min and loaded onto the gel, which was run at 200 V, 400 mA for 1 h. Following electrophoresis, gels were blotted onto PVDF membranes (Hybond P, Amersham Pharmacia) at 100 V, 1000 mA for 1 h and protein transfer checked by briefly immersing the membrane in Ponceau S solution (Sigma). Membranes were thoroughly washed in TBST (2 mM Tris/HCl, pH 7.6; 13.7 mM NaCl and 0.1% (v/v) Tween 20) and then blocked for 1 h in 5% (w/v) non-fat milk/TBST. Following another 3 × 15 min washes in TBST, membranes were incubated with the anti-His mouse antibody (Qiagen, 1:2000 in 3% (w/v) bovine serum albumin/TBST) overnight at 4°C. Following incubation with the secondary antibody (Anti-mouse IgG HRP, Southern Biotech) for 1 h, membranes were washed three times in TBST and developed with ChemiGlow^®^(Alpha Innotech) chemiluminescent substrate for 5 min. Images were obtained using a CCD camera system (ChemiImager 5500, Alpha Innotech). Protein bands on western blots were assigned values from 0 (no expression) to 4 (very strong band). Successful protein expression was defined for values of 2 to 4 and unsuccessful expression for values of 0 and 1. The ratings reflect the relative amount of human fusion protein compared to the reference protein (positive control). 4 ≥ reference protein; 3 ≥ 50% of r. p.; 2 ≥ 10% of r. p.; no expression \<1\< 10% of r.p.; 0 = no expression.
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